Conor McNamara
Stock Analyst at RBC Capital
(0)
# 4867
Out of 5,332 analysts
110
Total ratings
10.00%
Success rate
-27.64%
Average return
Main Sectors:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
HOLX Hologic | Maintains: Sector Perform | 75 70 | 53.16 | 31.68% | 10 | May 2, 2025 | |
BIO Bio-Rad Laboratories | Maintains: Outperform | 409 392 | 231.9 | 69.04% | 11 | May 2, 2025 | |
RGEN Repligen | Maintains: Outperform | 202 189 | 130.57 | 44.75% | 11 | Apr 30, 2025 | |
AVTR Avantor | Maintains: Outperform | 24 20 | 12 | 66.67% | 7 | Apr 28, 2025 | |
TMO Thermo Fisher Scient... | Maintains: Outperform | 651 637 | 407.79 | 56.21% | 14 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 250 250 | 190.15 | 31.48% | 9 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 128 112 | 74.61 | 50.11% | 15 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 7 4 | 1.55 | 158.06% | 3 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 251 | 155.48 | 61.44% | 1 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 64 61 | 25.95 | 135.07% | 11 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Sector Perform | 79 80 | 47.77 | 67.47% | 8 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 17 13 | 2.04 | 537.25% | 6 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 8 7 | 3 | 133.33% | 4 | Aug 7, 2024 |